Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 4Thoracic 2Head & Neck 2Genitourinary 2Gastrointestinal 2Other hematologic neoplasm 1Breast 1

Conditions

Breast Neoplasms 3Uterine Cervical Neoplasms 1Tobacco Use Disorder 1Prostatic Neoplasms 1Lung Neoplasms 1Head and Neck Neoplasms 1Hand-Foot Syndrome 1Colorectal Neoplasms 1Chemotherapy-Related Cognitive Impairment 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 24Nivolumab 7Early Intervention, Educational 7Methods 6durvalumab 5aldesleukin 5Trastuzumab 5Paclitaxel 5Fulvestrant 5Carboplatin 5atezolizumab 4Surveys and Questionnaires 4Patient Navigation 4Docetaxel 4Cyclophosphamide 4Biopsy 4fludarabine 3Mass Screening 3Magnetic Resonance Spectroscopy 3Ipilimumab 3Interleukin-2 3Gene Expression Profiling 3Fluorouracil 3Educational Status 3Bevacizumab 3tremelimumab 2spartalizumab 2sargramostim 2palbociclib 2fludarabine phosphate 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Uterine Cervical Neoplasms × Tobacco Use Cessation Devices × Breast × Clear all
NCT01434342 2021-09-28

Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients

Wake Forest University Health Sciences

Phase EARLY_PHASE1 Completed
146 enrolled 10 charts
BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Tobacco Use Disorder, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡